Hepatocyte growth factor-induced amelioration in renal interstitial fibrosis is associated with reduced expression of alpha-smooth muscle actin and transforming growth factor-beta1.

Wang, Hong-yue; Wang, Yan-jun; Cui, Ming-ji; Gu, Chun-mei; Yang, Li-zhi; Zhao, Ying; Chen, Yan; Zhao, Dan; Li, Tian-shu; Chi, Bao-rong

Wang, Hong-yue; Wang, Yan-jun; Cui, Ming-ji; Gu, Chun-mei; Yang, Li-zhi; Zhao, Ying; Chen, Yan; Zhao, Dan; Li, Tian-shu; Chi, Bao-rong.

Affiliation

Wang HY; Department of Nephrology, First Hospital of Jilin University, Changchun 130021, China.

Indian J Biochem Biophys ; 48(5): 308-15, 2011 Oct.

Article in En | MEDLINE | ID: mdl-22165288

Subject(s)

Actins/drug effects; Hepatocyte Growth Factor/therapeutic use; Kidney Diseases/drug therapy; Kidney/pathology; Transforming Growth Factor beta1/drug effects; Actins/metabolism; Animals; Fibrosis/drug therapy; Fibrosis/metabolism; Fibrosis/pathology; Hepatocyte Growth Factor/pharmacokinetics; Kidney Diseases/metabolism; Male; Random Allocation; Rats; Transforming Growth Factor beta1/metabolism

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Actins / Hepatocyte Growth Factor / Transforming Growth Factor beta1 / Kidney / Kidney Diseases Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Indian J Biochem Biophys Year: 2011 Type: Article Affiliation country: China

Search on Google

XML

PubMed Links